Published in Int J Ophthalmol on June 18, 2014
Association of insulin treatment versus oral hypoglycaemic agents with diabetic retinopathy and its severity in type 2 diabetes patients in Cameroon, sub-Saharan Africa. Ann Transl Med (2016) 0.78
Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis. BMC Endocr Disord (2017) 0.75
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53
The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA (2006) 11.78
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care (2003) 6.63
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes (2008) 4.05
Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA (2006) 2.97
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab (2005) 2.88
Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (1997) 2.31
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia (2001) 2.25
Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia (2004) 1.67
The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia (1992) 1.47
Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol (1998) 1.42
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol (2004) 1.39
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab (1993) 1.29
Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care (2005) 1.17
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol (1998) 1.12
Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care (2009) 1.11
Postprandial glucose improves the risk prediction of cardiovascular death beyond the metabolic syndrome in the nondiabetic population. Diabetes Care (2009) 1.08
Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int (2001) 1.06
Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci (1999) 0.99
[Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2004) 0.96
Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care (1998) 0.92
Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care (1998) 0.91
Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes (1995) 0.89
Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide. Diabetes Res Clin Pract (1991) 0.85
A community-based study of the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type II diabetics in Kinmen, Taiwan. Ophthalmic Epidemiol (2007) 0.82
Epidemiological data on postprandial glycaemia. Diabetes Metab (2006) 0.81
A community-based epidemiologic study of gender differences in the relationship between insulin resistance/beta-cell dysfunction and diabetic retinopathy among type 2 diabetic patients in Kinmen, Taiwan. Ophthalmologica (2006) 0.79
Insulin enhances leukocyte-endothelial cell adhesion in the retinal microcirculation through surface expression of intercellular adhesion molecule-1. Microvasc Res (2005) 0.78
The endogenous insulin secretion was suppressed during insulin therapy in NIDDM patients. Diabetes Res Clin Pract (1990) 0.76